A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 studyResearch Article Published on 2020-12-042024-09-02 Journal: BMC Cancer [Category] 대상포진, [키워드] adjuvant chemotherapy lymphovascular invasion Non-small cell lung cancer Phase II study targeted therapy Tegafur-uracil [DOI] 10.1186/s12885-020-07691-7 PMC 바로가기 [Article Type] Research Article
A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19Review article Published on 2020-12-012022-10-05 Journal: European journal of cancer (Oxford, England : 1990 [Category] Coronavirus, SARS, 치료법, [키워드] active cancer calculate cancer patient Cancer patients cancer treatment Chemotherapy confounding variable COVID-19 COVID-19 diagnosis COVID-19 pandemic database death Immunotherapy increased mortality increased the risk Meta-analysis mortality rate Odds ratio outcome pandemic Quality Radiotherapy Result risk SARS-CoV-2 searched severe COVID-19 severe disease severity of COVID-19 solid malignancies systematic review targeted therapy Therapies treated Treatment was used with COVID-19 [DOI] 10.1016/j.ejca.2020.09.028 [Article Type] Review article
Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish PopulationArticle Published on 2020-11-252022-10-31 Journal: Cancers [Category] COVID-19, [키워드] affected antineoplastic drugs Cancer cancer patient Cancer patients cancer treatment Care carried Characteristics Chemotherapy Cohort Confirmed COVID-19 infection coronavirus 2 coronavirus disease COVID-19 COVID-19 infection COVID-19-related symptoms diagnosed died disease evaluate Evolution First wave General population health emergency help higher risk hospital ICU immunosuppressive therapies immunosuppressive therapy Immunotherapy Impact impacted Infection information knowledge lack management material no significant difference outcome pandemic Patient patients patients hospitalized Patients with cancer performed Population positive Prevalence receiving required respiratory Retrospective analysis risk RT-PCR SARS-CoV-2 SARS-COV-2 infection Seroconversion seroconversion rate Seroprevalence simple Spanish Symptom targeted therapy tested the disease therapy Treatment [DOI] 10.3390/cancers12123513 PMC 바로가기 [Article Type] Article
A Novel Coronavirus Disease (COVID-19): a Review of Host Cell Signaling PathwaysReview Article Published on 2020-11-012022-10-28 Journal: Tanaffos [Category] COVID-19, [키워드] acute respiratory syndrome caused changes in coronavirus coronavirus disease CoV COVID-19 CoVs develop evaluate genetic variants Health Healthcare system Host host cell host cell factor host-pathogen interaction host-pathogen interactions Inflammation innate immune system Interaction lung Lung inflammation molecular novel pandemic persistence physician positive-sense progression proliferation promote recognize reduce review risk RNA viruses SARS-CoV-2 signaling pathway signaling pathways targeted therapy PMC 바로가기 [Article Type] Review Article
COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul신장 이식 환자의 COVID-19: 이스탄불의 다기관 경험Multicenter Study Published on 2020-10-012022-09-11 Journal: Transplant infectious disease : an official journa [Category] MERS, SARS, 진단, 치료제, [키워드] acute kidney Acute kidney injury Admission Adult all-cause mortality Analysis Antiviral Antiviral agents average Consensus COVID-19 cyclosporine cyclosporine A cytokine cytokine release Cytokine release syndrome cytokine-targeted therapy diagnosed with COVID-19 distress Dyspnea Fever FIVE Follow-up follow-up period Frequency Hospital stay Immunosuppression include induction Infection intensive care intensive care unit İstanbul kidney kidney transplant kidney transplant recipient kidney transplant recipients Kidney transplantation material mechanical ventilation moderate multicenter pandemic Patient patients patients died Pneumonia primary endpoint recipient reduced Regulation rejection respiratory distress Respiratory distress syndrome retrospective cohort study secondary endpoint Secondary endpoints severe pneumonia significantly higher supportive therapy Symptom syndrome targeted therapy the patient therapy Treatment Turkey [DOI] 10.1111/tid.13371 PMC 바로가기 [Article Type] Multicenter Study
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort Research Published on 2020-09-222022-10-05 Journal: Nature cancer [Category] SARS, 임상, 치료법, [키워드] age C-reactive protein Cancer Chemotherapy Cohort Cooperative COVID-19 D-dimer level death determinant died group Gustave Roussy Hospitalized Immunosuppression Immunotherapy impacted increased risk lactate dehydrogenase malignancy management median metastatic disease multivariable analysis outcome Patient patients Patients with cancer remained risk severe COVID-19 significantly smoking status targeted therapy therapeutic strategy therapy Treatment worsening [DOI] 10.1038/s43018-020-00120-5 [Article Type] Research
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in MadridOncology Published on 2020-09-162022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] abnormality acute respiratory distress Admission affected Anti-viral treatment anticoagulation ARDS baseline cancer patient cancer treatment conditions coronavirus Corticosteroids cough COVID-19 COVID-19 illness D-dimer diagnosed with COVID-19 Diagnosis discharged elevated Fever fibrinogen first positive high mortality rate high variability hospital Hospitalization hospitalized patient Hydroxychloroquine Immunotherapy incidence inflammation marker Inflammatory invasive lab lung cancer lung cancer patient lung cancer patients lymphocyte measure Mortality Multiple multivariate multivariate model neutrophil no difference outcome pandemic Patient patients PCR Pneumonia PROTECT Protein receiving risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR SARS-CoV-2 RT-PCR Shortness of breath Spain statistically significant symptoms onset syndrome targeted therapy Tertiary therapy Thoracic time Tocilizumab Treatment variable [DOI] 10.3389/fonc.2020.01777 PMC 바로가기 [Article Type] Oncology
Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) – novel approaches and future outlookReview Published on 2020-09-112023-08-30 Journal: Molecular Cancer [Category] E형 간염, [키워드] Immunotherapy resistance NSCLC targeted therapy Tumor microenvironment heterogeneity [DOI] 10.1186/s12943-020-01260-z PMC 바로가기 [Article Type] Review
Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19Oncology Published on 2020-08-282022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] addition adverse outcome Affect age Anxiety applied Breast cancer breast cancer patient Cancer cancer patient cancers Care center Chemotherapy Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) coronavirus disease 2019 (COVID-19) fear coronavirus disease 2019 (COVID-19) knowledge COVID-19 COVID-19 knowledge determine expected fear Immunotherapy improvement infecting information knowledge moderate Most patient oncologic care pandemic Patient Patient education patients Perspective Protective Quality of life question questionnaire resource significantly social media Stress targeted therapy the patient Topic university with COVID-19 younger patients [DOI] 10.3389/fonc.2020.01553 PMC 바로가기 [Article Type] Oncology
Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case ReportCOVID-19 Case Report Published on 2020-08-222022-10-31 Journal: Clinical Practice and Cases in Emergency Medicine [Category] COVID-19, [키워드] abnormality acute respiratory syndrome acute transverse myelitis ATM Central nervous system Cerebrovascular disease clinician CNS coronavirus coronavirus 2 Corticosteroid Critical Diagnosis discharge disease exhibiting hosts implicated intravenous male Myelitis Neuroinvasive neurological Neurological complications neurotropic pandemic Para-infectious Acute Transverse Myelitis Pathogens Patient patient population Post-infectious Acute Transverse Myelitis report respiratory respiratory viral SARS-CoV-2 SARS-COV-2 infection secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain Symptom syndrome targeted therapy the Coronaviridae Thoracic Transverse Treatment Urinary incontinence Viral illness weakness while [DOI] 10.5811/cpcem.2020.6.48462 PMC 바로가기 [Article Type] COVID-19 Case Report